Results 261 to 270 of about 303,277 (299)

Recurrent hypofibrinogenemia with interleukin-6 inhibitors tocilizumab and sarilumab: A case report

Journal of Hematology and Allied Sciences
Hypofibrinogenemia is a rare but clinically significant adverse effect of interleukin-6 (IL-6) receptor blockade, most associated with tocilizumab. We present a case of recurrent hypofibrinogenemia in an elderly patient with seronegative rheumatoid arthritis who developed bleeding complications during tocilizumab therapy and subsequently experienced ...
Amir Warwar, Amir Haddad, Marwa Naamneh, Meir Preis   +3 more
openaire   +1 more source

Plasma levels of interleukin‐6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder

Human psychopharmacology, 2013
R. Yoshimura, H. Hori, A. Ikenouchi‐Sugita, W. Umene‐Nakano, A. Katsuki, K. Atake, J. Nakamura   +6 more
semanticscholar   +1 more source

Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3-selective inhibitor reduces interleukin-6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients.

Arthritis & Rheumatism, 2012
J. Gillespie, S. Savic, C. Wong, Aiden Hempshall, M. Inman, P. Emery, R. Grigg, M. McDermott   +7 more
semanticscholar   +1 more source

Interleukin 6 enhances the production of tissue inhibitor of metalloproteinases (TIMP) but not that of matrix metalloproteinases by human fibroblasts.

Biochemical and Biophysical Research Communications - BBRC, 1990
Takashi Sato, A. Ito, Yo Mori
semanticscholar   +1 more source

Leprosy after interleukin 6 inhibitor therapy in a patient with rheumatoid arthritis

The Lancet Infectious Diseases, 2019
Puja H, Nambiar, Mamatha, Katikaneni, Basma, Al Nahlawi, Samina Q, Hayat   +3 more
openaire   +2 more sources

Reasons for the Termination of Interleukin-17 Inhibitor Medications in the Treatment of Plaque Psoriasis: A Real-World Retrospective Study

Journal of Cutaneous Medicine and Surgery, 2023
Athalia Voisin, Abrahim Abduelmula, Melinda Gooderham   +2 more
exaly  

Interleukin‐6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression

The Prostate, 2007
Soo Ok Lee, J. Chun, N. Nadiminty, W. Lou, A. Gao   +4 more
semanticscholar   +1 more source

Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor.

Journal of Experimental Medicine, 1986
R L Nachman, Katherine A Hajjar, R L Silverstein   +2 more
exaly  

Gene regulation of interleukin-1β, interleukin-1 receptor type I, and plasminogen activator inhibitor-1 and -2 in human granulosa-luteal cells

Fertility and Sterility, 1994
CARLOS Simon, Mary Lake Polan, A Frances   +2 more
exaly  

Lyt-23+ cyclophosphamide-sensitive T cells regulate the activity of an interleukin 2 inhibitor in vivo.

Journal of Experimental Medicine, 1981
C Hardt, Martin Röllinghoff, K Pfizenmaier   +2 more
exaly